$1.08
0[0.00%]
At close: May 30
Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|
There is no price target for Biofrontera.
There is no analyst for Biofrontera.
There is no last upgrade for Biofrontera.
There is no last downgrade for Biofrontera.
There is no next analyst rating for Biofrontera.
There is no next analyst rating for Biofrontera.
Browse analyst ratings and price targets on all stocks.